[{"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-001", "question": "A 34-year-old professional baseball pitcher presents with progressive shoulder pain and weakness during the late cocking phase of throwing. MRI reveals a partial articular-sided supraspinatus tear with a posterosuperior labral tear. Physical examination demonstrates 145 degrees of external rotation and only 25 degrees of internal rotation in 90 degrees of abduction. The total arc of motion is preserved compared to the contralateral side. Which biomechanical adaptation is the PRIMARY contributor to this pathology?", "options": ["Anterior capsular laxity with increased humeral head translation", "Posterior capsular contracture with posterosuperior humeral head migration", "Scapular dyskinesis with altered glenohumeral kinematics", "Rotator cuff fatigue with dynamic superior humeral head migration", "Biceps tendon subluxation with altered force coupling"], "answer": "B", "answer_index": 1, "explanation": "This presentation describes glenohumeral internal rotation deficit (GIRD) with internal impingement syndrome. Posterior capsular contracture shifts the glenohumeral contact point posterosuperiorly during abduction and external rotation, causing the greater tuberosity to impinge on the posterosuperior labrum and articular surface of the rotator cuff. While anterior laxity and scapular dyskinesis may contribute, the primary biomechanical driver is posterior capsular tightness causing the characteristic GIRD pattern with preserved total arc of motion.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: professional overhead-throwing athlete; pain and weakness in late cocking phase; MRI with partial articular-sided supraspinatus tear and posterosuperior labral tear (classic internal impingement pattern); physical exam with 145° ER and only 25° IR at 90° abduction, but preserved total arc compared with contralateral side (defining glenohumeral internal rotation deficit, GIRD). These findings strongly point to posterior capsular tightness as the primary biomechanical adaptation shifting the humeral head contact point posterosuperiorly, leading to internal impingement and articular-sided cuff/labral pathology.\\nChoice B (posterior capsular contracture with posterosuperior humeral head migration) matches this mechanism and the explanation. A (anterior capsular laxity) may coexist but is not the primary driver in classic GIRD with preserved total arc. C (scapular dyskinesis), D (rotator cuff fatigue), and E (biceps subluxation) are contributing or alternative factors but do not explain the specific ROM pattern plus lesion combination as well as B.\\nNo major logical or internal inconsistencies are present; a single best answer is supported.\\nMinimal fix: Add the term “glenohumeral internal rotation deficit (GIRD)” explicitly in the stem to reinforce the intended diagnosis and teaching point, though not strictly necessary.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: professional overhead-throwing athlete; pain and weakness in late cocking phase; MRI with partial articular-sided supraspinatus tear and posterosuperior labral tear (classic internal impingement pattern); physical exam with 145° ER and only 25° IR at 90° abduction, but preserved total arc compared with contralateral side (defining glenohumeral internal rotation deficit, GIRD). These findings strongly point to posterior capsular tightness as the primary biomechanical adaptation shifting the humeral head contact point posterosuperiorly, leading to internal impingement and articular-sided cuff/labral pathology.\nChoice B (posterior capsular contracture with posterosuperior humeral head migration) matches this mechanism and the explanation. A (anterior capsular laxity) may coexist but is not the primary driver in classic GIRD with preserved total arc. C (scapular dyskinesis), D (rotator cuff fatigue), and E (biceps subluxation) are contributing or alternative factors but do not explain the specific ROM pattern plus lesion combination as well as B.\nNo major logical or internal inconsistencies are present; a single best answer is supported.\nMinimal fix: Add the term “glenohumeral internal rotation deficit (GIRD)” explicitly in the stem to reinforce the intended diagnosis and teaching point, though not strictly necessary.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-002", "question": "A 52-year-old woman with a 15-year history of dermatomyositis presents with a new 2.5 cm erythematous, indurated plaque on her left thigh that has been present for 8 months. Biopsy reveals atypical lymphoid infiltrate with CD4+, CD8-, and loss of CD7 expression. TCR gene rearrangement studies demonstrate a monoclonal population. PET-CT shows no evidence of systemic disease. Which statement regarding this patient's condition is MOST accurate?", "options": ["This represents transformation of dermatomyositis to systemic T-cell lymphoma requiring CHOP chemotherapy", "This is a primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder with excellent prognosis", "The dermatomyositis was likely a paraneoplastic phenomenon of an underlying T-cell lymphoma", "This represents mycosis fungoides arising in the setting of chronic inflammation requiring total skin electron beam therapy", "Immediate allogeneic stem cell transplantation is indicated given the immunocompromised state"], "answer": "B", "answer_index": 1, "explanation": "Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PC-SMLPD) is a provisional entity in the WHO classification characterized by solitary or localized lesions with CD4+CD8- phenotype and clonal TCR rearrangement. Despite the alarming histopathology, it has an indolent course with excellent prognosis (>95% 5-year survival) and is typically managed with local therapy alone. This is distinct from systemic T-cell lymphomas and mycosis fungoides, which have different clinical presentations and prognoses.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Long-standing dermatomyositis; new solitary 2.5‑cm erythematous indurated plaque; biopsy with atypical CD4+ CD8– T cells and loss of CD7; monoclonal TCR rearrangement; PET‑CT negative for systemic disease; question asks for the most accurate statement about this condition.\\nThese features are classic for primary cutaneous CD4+ small/medium T‑cell lymphoproliferative disorder (PC‑SMLPD): typically solitary/localized lesions, CD4+CD8− phenotype, clonal TCR, and no systemic involvement, with an excellent prognosis and local management. Thus option B correctly describes the entity.\\nOther options: A is incorrect because this is not systemic T‑cell lymphoma nor “transformation” of dermatomyositis, and CHOP is not indicated. C is speculative and not supported by the current timing and localized lesion. D describes mycosis fungoides, which usually presents with patches/plaques over broader skin areas and different clinical context; TSEBT is not first‑line here. E is inappropriate and excessively aggressive; stem cell transplant is not indicated for this indolent cutaneous process.\\nNo major medical inaccuracies or logical flaws are evident.\\nMinimal fix: Option B could explicitly include “solitary/localized lesion” to further anchor the diagnosis, but it is already clear and defensible.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Long-standing dermatomyositis; new solitary 2.5‑cm erythematous indurated plaque; biopsy with atypical CD4+ CD8– T cells and loss of CD7; monoclonal TCR rearrangement; PET‑CT negative for systemic disease; question asks for the most accurate statement about this condition.\nThese features are classic for primary cutaneous CD4+ small/medium T‑cell lymphoproliferative disorder (PC‑SMLPD): typically solitary/localized lesions, CD4+CD8− phenotype, clonal TCR, and no systemic involvement, with an excellent prognosis and local management. Thus option B correctly describes the entity.\nOther options: A is incorrect because this is not systemic T‑cell lymphoma nor “transformation” of dermatomyositis, and CHOP is not indicated. C is speculative and not supported by the current timing and localized lesion. D describes mycosis fungoides, which usually presents with patches/plaques over broader skin areas and different clinical context; TSEBT is not first‑line here. E is inappropriate and excessively aggressive; stem cell transplant is not indicated for this indolent cutaneous process.\nNo major medical inaccuracies or logical flaws are evident.\nMinimal fix: Option B could explicitly include “solitary/localized lesion” to further anchor the diagnosis, but it is already clear and defensible.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-003", "question": "A 67-year-old man undergoes robot-assisted radical prostatectomy for Gleason 4+3=7 prostate cancer. Final pathology reveals pT3aN0 disease with positive surgical margins at the apex. PSA at 6 weeks is undetectable. At 18 months, PSA rises to 0.35 ng/mL. PSMA-PET scan shows a single 8mm focus of uptake in the right obturator lymph node with SUVmax of 12. No other sites of disease are identified. Which management strategy offers the BEST oncologic outcome based on current evidence?", "options": ["Observation with serial PSA monitoring until symptomatic progression", "Androgen deprivation therapy alone for 24 months", "Salvage radiation therapy to the prostate bed alone (66-70 Gy)", "Salvage radiation therapy to prostate bed plus elective nodal irradiation with short-term ADT", "Stereotactic body radiation therapy to the PSMA-avid lymph node alone"], "answer": "D", "answer_index": 3, "explanation": "The SPPORT trial and subsequent analyses demonstrate that for biochemical recurrence after prostatectomy, salvage radiation to the prostate bed combined with pelvic lymph node irradiation and short-term ADT (4-6 months) provides superior freedom from progression compared to prostate bed radiation alone. While SBRT to oligometastatic disease is emerging, current evidence supports comprehensive salvage therapy. The PSMA-PET finding of nodal disease supports inclusion of elective nodal fields, as micrometastatic disease beyond the visible lesion is likely present.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Post-prostatectomy pT3a, positive margin, initially undetectable PSA; biochemical recurrence at 18 months with PSA 0.35 ng/mL; PSMA-PET–positive single pelvic (obturator) node; question asks for BEST oncologic outcome per current evidence.\\n\\nMost likely clinical scenario is early biochemical recurrence with PSMA-detected pelvic nodal disease. High-level data (e.g., SPPORT/RTOG 0534 and related evidence) support salvage RT to prostate bed plus pelvic nodal irradiation with short-term ADT as superior to prostate bed alone for progression-free outcomes in this setting, and PSMA-avid pelvic node further justifies including nodal fields due to likely microscopic spread.\\n\\nOption D matches this approach and rationally extrapolates existing evidence to PSMA-era imaging. Options A (observation) and B (ADT alone) under-treat and are inferior oncologically. C omits nodal RT despite nodal involvement and evidence favoring nodal fields. E (SBRT to node only) ignores the high risk of occult disease in the bed and other pelvic nodes and lacks comparable level-1 evidence.\\n\\nMinimal fix: Explicitly acknowledge that evidence is extrapolated from trials using conventional imaging (e.g., “Based on level 1 data in conventionally imaged patients…”).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Post-prostatectomy pT3a, positive margin, initially undetectable PSA; biochemical recurrence at 18 months with PSA 0.35 ng/mL; PSMA-PET–positive single pelvic (obturator) node; question asks for BEST oncologic outcome per current evidence.\n\nMost likely clinical scenario is early biochemical recurrence with PSMA-detected pelvic nodal disease. High-level data (e.g., SPPORT/RTOG 0534 and related evidence) support salvage RT to prostate bed plus pelvic nodal irradiation with short-term ADT as superior to prostate bed alone for progression-free outcomes in this setting, and PSMA-avid pelvic node further justifies including nodal fields due to likely microscopic spread.\n\nOption D matches this approach and rationally extrapolates existing evidence to PSMA-era imaging. Options A (observation) and B (ADT alone) under-treat and are inferior oncologically. C omits nodal RT despite nodal involvement and evidence favoring nodal fields. E (SBRT to node only) ignores the high risk of occult disease in the bed and other pelvic nodes and lacks comparable level-1 evidence.\n\nMinimal fix: Explicitly acknowledge that evidence is extrapolated from trials using conventional imaging (e.g., “Based on level 1 data in conventionally imaged patients…”).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-004", "question": "A 58-year-old man presents with progressive dysphagia to solids over 6 months and a 15-pound weight loss. He has a 40-pack-year smoking history. Flexible laryngoscopy reveals a fungating mass involving the right pyriform sinus with extension to the postcricoid region and fixation of the right vocal cord. CT shows a 4.2 cm mass with cartilage invasion and two ipsilateral lymph nodes measuring 2.1 cm and 1.8 cm. PET-CT shows no distant metastases. What is the MOST appropriate initial management?", "options": ["Total laryngopharyngectomy with bilateral neck dissection and free flap reconstruction", "Definitive chemoradiation with cisplatin-based concurrent chemotherapy", "Induction chemotherapy with TPF followed by chemoradiation for responders", "Transoral robotic surgery with adjuvant radiation therapy", "Larynx-preservation protocol with carboplatin/paclitaxel and radiation"], "answer": "A", "answer_index": 0, "explanation": "This patient has a T4a (cartilage invasion) hypopharyngeal squamous cell carcinoma with N2b nodal disease. Hypopharyngeal cancers, particularly those involving the postcricoid region with cartilage invasion and vocal cord fixation, have poor outcomes with organ preservation approaches compared to laryngeal primaries. The RTOG 91-11 larynx preservation data does not apply to hypopharyngeal cancers. For T4a hypopharyngeal cancer with cartilage invasion, primary surgical resection with total laryngopharyngectomy, bilateral neck dissection, and reconstruction followed by adjuvant therapy offers the best oncologic outcome.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 58-year-old man; progressive dysphagia and weight loss; fungating mass in right pyriform sinus extending to postcricoid region; fixation of right vocal cord; CT with 4.2‑cm mass, cartilage invasion; two ipsilateral nodes >1 cm; PET-CT negative for distant disease. These features define a locally advanced, resectable T4a hypopharyngeal SCC with N2b nodal disease and poor prognosis with organ-preservation strategies.\\nRationale for keyed answer (A): T4a hypopharyngeal tumors with cartilage invasion and postcricoid involvement are standardly managed with primary surgical resection (total laryngopharyngectomy) and bilateral neck dissection plus reconstruction, followed by risk‑adapted adjuvant therapy. Organ-preservation data (e.g., RTOG 91‑11) primarily apply to laryngeal, not hypopharyngeal primaries.\\nWhy other options are worse: B and E (definitive chemoradiation/larynx preservation) are associated with inferior local control and survival in T4a hypopharyngeal disease with cartilage invasion. C (induction chemotherapy) is not standard first‑line for clearly resectable T4a hypopharynx. D (transoral robotic surgery) is inappropriate for large postcricoid/pyriform sinus tumors with cartilage invasion and fixed cord.\\nMain medical issues: None significant; staging and management align with current standards.\\nMinimal fix: Explicitly state tumor is resectable and patient is medically fit for major surgery to preempt ambiguity about candidacy for laryngopharyngectomy.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 58-year-old man; progressive dysphagia and weight loss; fungating mass in right pyriform sinus extending to postcricoid region; fixation of right vocal cord; CT with 4.2‑cm mass, cartilage invasion; two ipsilateral nodes >1 cm; PET-CT negative for distant disease. These features define a locally advanced, resectable T4a hypopharyngeal SCC with N2b nodal disease and poor prognosis with organ-preservation strategies.\nRationale for keyed answer (A): T4a hypopharyngeal tumors with cartilage invasion and postcricoid involvement are standardly managed with primary surgical resection (total laryngopharyngectomy) and bilateral neck dissection plus reconstruction, followed by risk‑adapted adjuvant therapy. Organ-preservation data (e.g., RTOG 91‑11) primarily apply to laryngeal, not hypopharyngeal primaries.\nWhy other options are worse: B and E (definitive chemoradiation/larynx preservation) are associated with inferior local control and survival in T4a hypopharyngeal disease with cartilage invasion. C (induction chemotherapy) is not standard first‑line for clearly resectable T4a hypopharynx. D (transoral robotic surgery) is inappropriate for large postcricoid/pyriform sinus tumors with cartilage invasion and fixed cord.\nMain medical issues: None significant; staging and management align with current standards.\nMinimal fix: Explicitly state tumor is resectable and patient is medically fit for major surgery to preempt ambiguity about candidacy for laryngopharyngectomy.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-005", "question": "A 42-year-old woman with multiple sclerosis presents for evaluation of neurogenic bladder. Urodynamic studies reveal detrusor overactivity with detrusor-sphincter dyssynergia, maximum detrusor pressure of 65 cmH2O during involuntary contractions, and post-void residual of 280 mL. She has been performing clean intermittent catheterization 4 times daily and taking oxybutynin 5mg TID with inadequate symptom control and intolerable anticholinergic side effects. Renal ultrasound shows mild bilateral hydronephrosis. Which intervention provides the MOST durable improvement in upper tract protection while maintaining quality of life?", "options": ["Increase anticholinergic dose with addition of mirabegron", "Sacral neuromodulation with InterStim device", "Intradetrusor onabotulinumtoxinA injection 200 units", "Augmentation cystoplasty with continent catheterizable channel", "Sphincterotomy with condom catheter drainage"], "answer": "C", "answer_index": 2, "explanation": "For neurogenic detrusor overactivity with detrusor-sphincter dyssynergia refractory to oral anticholinergics, intradetrusor onabotulinumtoxinA injection (200 units for neurogenic bladder) provides effective reduction in detrusor pressures and protection of the upper tracts while maintaining continence with CIC. It has Level A evidence for neurogenic bladder. Sacral neuromodulation has limited efficacy in complete neurogenic bladder. Augmentation cystoplasty is more invasive and reserved for refractory cases. Sphincterotomy would eliminate continence. The mild hydronephrosis indicates need for intervention to reduce storage pressures.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: MS with neurogenic detrusor overactivity + detrusor-sphincter dyssynergia; high detrusor pressure (65 cmH2O), large PVR (280 mL); already on CIC and low‑dose oxybutynin with inadequate control and intolerable side effects; mild bilateral hydronephrosis (threat to upper tracts); question asks for MOST durable improvement in upper tract protection while maintaining quality of life.\\nOnabotulinumtoxinA 200 U (C) has strong evidence in neurogenic detrusor overactivity to reduce storage pressures, improve continence while continuing CIC, and protect kidneys, matching current guidelines (AUA/SUFU, EAU). A) Escalating anticholinergics plus mirabegron is unlikely to be tolerated given existing side effects and often inadequate for such high pressures. B) Sacral neuromodulation is generally less effective in MS with significant neurogenic dysfunction and not first-line for high-risk upper tract issues. D) Augmentation cystoplasty is more invasive, reserved for failure of less invasive therapies, despite being durable. E) Sphincterotomy sacrifices continence and uses condom drainage, impairing quality of life.\\nNo major logical or medical inaccuracies; item supports a single best answer consistent with the key.\\nMinimal fix: Explicitly note that her MS is stable/incomplete to further justify limited role of sacral neuromodulation, though current wording is adequate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: MS with neurogenic detrusor overactivity + detrusor-sphincter dyssynergia; high detrusor pressure (65 cmH2O), large PVR (280 mL); already on CIC and low‑dose oxybutynin with inadequate control and intolerable side effects; mild bilateral hydronephrosis (threat to upper tracts); question asks for MOST durable improvement in upper tract protection while maintaining quality of life.\nOnabotulinumtoxinA 200 U (C) has strong evidence in neurogenic detrusor overactivity to reduce storage pressures, improve continence while continuing CIC, and protect kidneys, matching current guidelines (AUA/SUFU, EAU). A) Escalating anticholinergics plus mirabegron is unlikely to be tolerated given existing side effects and often inadequate for such high pressures. B) Sacral neuromodulation is generally less effective in MS with significant neurogenic dysfunction and not first-line for high-risk upper tract issues. D) Augmentation cystoplasty is more invasive, reserved for failure of less invasive therapies, despite being durable. E) Sphincterotomy sacrifices continence and uses condom drainage, impairing quality of life.\nNo major logical or medical inaccuracies; item supports a single best answer consistent with the key.\nMinimal fix: Explicitly note that her MS is stable/incomplete to further justify limited role of sacral neuromodulation, though current wording is adequate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-006", "question": "A 28-year-old woman undergoes deep inferior epigastric perforator (DIEP) flap breast reconstruction following mastectomy. On postoperative day 1, the flap appears congested with rapid capillary refill, dark purple color, and brisk dark bleeding on pinprick. Doppler signals show arterial inflow but absent venous outflow. Immediate surgical exploration reveals thrombosis of the venous anastomosis. After successful thrombectomy and revision of the anastomosis, which adjunctive measure has the STRONGEST evidence for improving flap salvage in this scenario?", "options": ["Systemic heparinization with aPTT goal 60-80 seconds", "Application of medicinal leeches to the flap surface", "Topical nitroglycerin paste to the flap skin paddle", "Hyperbaric oxygen therapy at 2.4 ATA for 90 minutes daily", "Intravenous dextran-40 infusion at 25 mL/hour"], "answer": "B", "answer_index": 1, "explanation": "Medicinal leeches (Hirudo medicinalis) provide the most effective adjunctive treatment for venous congestion in free flaps after surgical revision. Leeches provide passive bleeding that decompresses the congested flap while their saliva contains hirudin (anticoagulant), hyaluronidase, and vasodilators that promote continued bleeding after detachment. This allows time for neovascularization. Systemic heparinization increases bleeding risk without addressing the mechanical congestion. Dextran-40 has fallen out of favor due to bleeding complications and anaphylaxis risk. Hyperbaric oxygen and topical nitroglycerin have limited evidence for acute venous congestion.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Free DIEP flap, early postoperative venous congestion (rapid cap refill, dark purple, brisk dark bleeding), confirmed venous thrombosis at anastomosis, successful surgical revision, question asks for adjunctive measure with strongest evidence for improving flap salvage. For microsurgical free flap venous congestion that has been surgically corrected but remains at risk, medicinal leeches are well established as the primary evidence-based adjunct to decompress venous-congested tissue, especially in breast and head/neck reconstruction.\\nEvaluation of alternatives: Systemic heparinization (A) does not relieve mechanical venous outflow obstruction and increases bleeding risk. Topical nitroglycerin (C) improves arterial inflow/vasodilation but is not a primary treatment for severe venous congestion. Hyperbaric oxygen (D) has limited and weak evidence in this specific acute setting. Dextran-40 (E) is largely abandoned due to bleeding/anaphylaxis with no clear benefit.\\nMain issues: None significant; the stem is clear, timing is appropriate, and the question explicitly focuses on “strongest evidence,” which favors leech therapy over other listed adjuncts.\\nMinimal fix: Optionally specify that congestion persists after revision despite patent anastomosis to more clearly justify need for adjunctive decompression therapy (leeches).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Free DIEP flap, early postoperative venous congestion (rapid cap refill, dark purple, brisk dark bleeding), confirmed venous thrombosis at anastomosis, successful surgical revision, question asks for adjunctive measure with strongest evidence for improving flap salvage. For microsurgical free flap venous congestion that has been surgically corrected but remains at risk, medicinal leeches are well established as the primary evidence-based adjunct to decompress venous-congested tissue, especially in breast and head/neck reconstruction.\nEvaluation of alternatives: Systemic heparinization (A) does not relieve mechanical venous outflow obstruction and increases bleeding risk. Topical nitroglycerin (C) improves arterial inflow/vasodilation but is not a primary treatment for severe venous congestion. Hyperbaric oxygen (D) has limited and weak evidence in this specific acute setting. Dextran-40 (E) is largely abandoned due to bleeding/anaphylaxis with no clear benefit.\nMain issues: None significant; the stem is clear, timing is appropriate, and the question explicitly focuses on “strongest evidence,” which favors leech therapy over other listed adjuncts.\nMinimal fix: Optionally specify that congestion persists after revision despite patent anastomosis to more clearly justify need for adjunctive decompression therapy (leeches).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-007", "question": "A 45-year-old woman presents with a 6-month history of progressive right arm weakness and numbness. MRI of the cervical spine reveals a 2.8 cm intradural extramedullary mass at C5-C6 with homogeneous enhancement, located lateral to the spinal cord with extension through the neural foramen. The mass has a characteristic dumbbell shape. Preoperative angiography shows the tumor is supplied by branches of the vertebral artery. Which surgical approach provides optimal tumor resection while minimizing risk of spinal instability?", "options": ["Posterior laminectomy with tumor resection and instrumented fusion", "Anterior corpectomy with tumor resection and cage reconstruction", "Combined posterior laminectomy and anterior corpectomy in staged procedures", "Posterior laminoplasty with tumor resection preserving facet joints", "Posterolateral approach with hemilaminectomy and partial facetectomy"], "answer": "E", "answer_index": 4, "explanation": "Dumbbell-shaped schwannomas with foraminal extension are optimally approached via a posterolateral approach with hemilaminectomy and partial facetectomy, which provides adequate exposure of both intraspinal and extraforaminal components while preserving contralateral posterior elements and minimizing destabilization. Complete laminectomy with bilateral facet disruption significantly increases instability risk requiring fusion. The anterior approach provides poor access to the intradural component. Laminoplasty is designed for multilevel stenosis, not tumor resection. Staged procedures add morbidity without benefit for this tumor configuration.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 45-year-old with 2.8 cm intradural extramedullary, homogeneously enhancing, lateral C5–C6 dumbbell-shaped mass extending through the neural foramen and fed by vertebral branches—classic for a cervical nerve sheath tumor with both intraspinal and foraminal/extraforaminal components. The question asks for the approach that allows adequate exposure of both components while minimizing risk of postoperative spinal instability.\\nOption E (posterolateral approach with hemilaminectomy and partial facetectomy) is the standard for foraminal/dumbbell cervical schwannomas, allowing circumferential control of the root and tumor while avoiding full laminectomy or bilateral facet disruption, thereby preserving stability. \\nOption A uses full laminectomy and fusion—more destabilizing and excessive for a unilateral lesion. \\nOption B (anterior corpectomy) poorly accesses the intradural posterior-lateral component. \\nOption C adds morbidity without clear indication in this configuration. \\nOption D (laminoplasty) is for multilevel stenosis and does not address the foraminal component adequately.\\nNo major internal contradictions or underspecification; a single best answer is clearly supported and medically up to date.\\nMinimal fix: Explicitly name the lesion as a schwannoma in the stem to tighten the teaching point, though it is already strongly implied.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 45-year-old with 2.8 cm intradural extramedullary, homogeneously enhancing, lateral C5–C6 dumbbell-shaped mass extending through the neural foramen and fed by vertebral branches—classic for a cervical nerve sheath tumor with both intraspinal and foraminal/extraforaminal components. The question asks for the approach that allows adequate exposure of both components while minimizing risk of postoperative spinal instability.\nOption E (posterolateral approach with hemilaminectomy and partial facetectomy) is the standard for foraminal/dumbbell cervical schwannomas, allowing circumferential control of the root and tumor while avoiding full laminectomy or bilateral facet disruption, thereby preserving stability. \nOption A uses full laminectomy and fusion—more destabilizing and excessive for a unilateral lesion. \nOption B (anterior corpectomy) poorly accesses the intradural posterior-lateral component. \nOption C adds morbidity without clear indication in this configuration. \nOption D (laminoplasty) is for multilevel stenosis and does not address the foraminal component adequately.\nNo major internal contradictions or underspecification; a single best answer is clearly supported and medically up to date.\nMinimal fix: Explicitly name the lesion as a schwannoma in the stem to tighten the teaching point, though it is already strongly implied.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-008", "question": "A 62-year-old man with locally advanced non-small cell lung cancer (stage IIIA, N2) completes definitive concurrent chemoradiation (60 Gy in 30 fractions with carboplatin/paclitaxel) followed by durvalumab consolidation. Eighteen months later, surveillance CT reveals a new 2.2 cm spiculated nodule in the previously irradiated right upper lobe. PET shows SUVmax of 8.5. Bronchoscopic biopsy confirms recurrent adenocarcinoma. Pulmonary function tests show FEV1 of 1.8L (65% predicted) and DLCO of 55% predicted. Which treatment approach is MOST appropriate?", "options": ["Stereotactic body radiation therapy (SBRT) 50 Gy in 5 fractions", "Salvage right upper lobectomy via thoracotomy", "Re-irradiation with conventional fractionation to 50 Gy", "Systemic therapy with pembrolizumab plus chemotherapy", "Radiofrequency ablation of the recurrent nodule"], "answer": "D", "answer_index": 3, "explanation": "For in-field recurrence after definitive chemoradiation for stage III NSCLC, re-irradiation carries significant risk of severe toxicity including fatal pulmonary hemorrhage and esophageal fistula, particularly in previously irradiated tissue. SBRT in previously irradiated fields has unacceptably high toxicity rates. Surgical salvage after 60 Gy is associated with high morbidity and mortality due to radiation-induced tissue changes. The patient has already received durvalumab, but systemic therapy with pembrolizumab plus chemotherapy (per KEYNOTE-789 for post-immunotherapy progression) represents the safest approach with meaningful efficacy for this recurrence pattern.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (underspecified)\\nVerdict on keyed answer: Not uniquely determinable\\n\\nKey stem clues: Prior definitive 60 Gy chemoradiation for stage IIIA N2 NSCLC; 18‑month interval to an isolated 2.2‑cm spiculated nodule within the prior field; biopsy‑proven recurrent adenocarcinoma; reasonable lung function (FEV1 65% predicted, DLCO 55%); prior durvalumab; options include local salvage (surgery, SBRT, conventional re‑RT, ablation) vs systemic therapy.\\n\\nMain logical issues: The question asks for the “MOST appropriate” treatment, but does not specify key determinants of local‑therapy feasibility: resectability (anatomic location, nodal status, cardiopulmonary reserve beyond FEV1/DLCO, surgical evaluation), performance status, and detailed dosimetric constraints. In contemporary practice, highly selected patients can undergo salvage surgery or carefully planned SBRT/re‑irradiation after chemoradiation; these are not categorically contraindicated. Thus, it is not possible to state that systemic pembrolizumab plus chemotherapy is clearly superior to all local options from the information provided. Multiple answers (B, possibly A/E) could be defensible depending on missing details, so a unique best answer cannot be identified.\\n\\nMedical accuracy: The blanket assertion that SBRT or surgery are “unacceptably” or uniformly high‑risk after 60 Gy is overstated and somewhat outdated; however, systemic therapy is a very reasonable choice.\\n\\nMinimal fix: Explicitly state that the recurrence is unresectable and not amenable to further local therapy (e.g., prior high‑dose central RT with prohibitive surgical risk), or remove local salvage options, to make systemic therapy uniquely best.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified)\nVerdict on keyed answer: Not uniquely determinable\n\nKey stem clues: Prior definitive 60 Gy chemoradiation for stage IIIA N2 NSCLC; 18‑month interval to an isolated 2.2‑cm spiculated nodule within the prior field; biopsy‑proven recurrent adenocarcinoma; reasonable lung function (FEV1 65% predicted, DLCO 55%); prior durvalumab; options include local salvage (surgery, SBRT, conventional re‑RT, ablation) vs systemic therapy.\n\nMain logical issues: The question asks for the “MOST appropriate” treatment, but does not specify key determinants of local‑therapy feasibility: resectability (anatomic location, nodal status, cardiopulmonary reserve beyond FEV1/DLCO, surgical evaluation), performance status, and detailed dosimetric constraints. In contemporary practice, highly selected patients can undergo salvage surgery or carefully planned SBRT/re‑irradiation after chemoradiation; these are not categorically contraindicated. Thus, it is not possible to state that systemic pembrolizumab plus chemotherapy is clearly superior to all local options from the information provided. Multiple answers (B, possibly A/E) could be defensible depending on missing details, so a unique best answer cannot be identified.\n\nMedical accuracy: The blanket assertion that SBRT or surgery are “unacceptably” or uniformly high‑risk after 60 Gy is overstated and somewhat outdated; however, systemic therapy is a very reasonable choice.\n\nMinimal fix: Explicitly state that the recurrence is unresectable and not amenable to further local therapy (e.g., prior high‑dose central RT with prohibitive surgical risk), or remove local salvage options, to make systemic therapy uniquely best.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-009", "question": "A 71-year-old man undergoes right pneumonectomy for centrally located squamous cell carcinoma. On postoperative day 8, he develops sudden onset of copious purulent sputum production, fever, and respiratory distress. Bronchoscopy reveals a 1.5 cm dehiscence of the bronchial stump with visible empyema cavity. The patient is hemodynamically stable after fluid resuscitation. Which management strategy is MOST appropriate?", "options": ["Immediate completion thoracoplasty with muscle flap coverage", "Open window thoracostomy (Eloesser flap) with delayed stump repair", "Endoscopic stump closure with fibrin glue and covered stent placement", "Chest tube drainage with broad-spectrum antibiotics and observation", "Transsternal transpericardial bronchial stump re-closure"], "answer": "B", "answer_index": 1, "explanation": "Post-pneumonectomy bronchopleural fistula (BPF) with empyema is a life-threatening complication requiring staged management. The initial priority is source control and drainage. Open window thoracostomy (Eloesser flap or Clagett procedure) provides dependent drainage, allows cavity sterilization, and converts the contaminated space to a controlled environment. Once the cavity is clean and granulating (typically 6-8 weeks), delayed closure with muscle flap transposition can be performed. Immediate thoracoplasty in an infected field has high failure rates. Endoscopic approaches are for small fistulas without empyema. Transsternal approach is overly morbid in this setting.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 71-year-old post-right pneumonectomy; POD 8 (early post-op); sudden copious purulent sputum, fever, respiratory distress; bronchoscopy shows 1.5 cm dehiscence of bronchial stump with visible empyema cavity; currently hemodynamically stable after fluids. This clearly describes an early, large post-pneumonectomy bronchopleural fistula with established empyema.\\nManagement principle is staged: urgent, effective drainage and control of infected pleural space, then delayed definitive stump repair and obliteration of cavity once infection controlled. Option B (open window thoracostomy/Eloesser) best matches standard thoracic surgery teaching for large BPF with empyema.\\nOption A (immediate thoracoplasty with flap) is discouraged in contaminated, infected fields due to high failure and sepsis risk. C (endoscopic closure with fibrin glue/stent) is reserved for small stump leaks without empyema. D (chest tube plus antibiotics) is inadequate for a large fistula with a pneumonectomy space empyema. E (transsternal transpericardial re-closure) is occasionally used for access to stumps but not as first-line in a grossly infected cavity.\\nNo major medical inaccuracies identified.\\nMinimal fix: Specify “large post-pneumonectomy bronchopleural fistula with empyema” in the stem to explicitly anchor the diagnosis and intent of management stage.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 71-year-old post-right pneumonectomy; POD 8 (early post-op); sudden copious purulent sputum, fever, respiratory distress; bronchoscopy shows 1.5 cm dehiscence of bronchial stump with visible empyema cavity; currently hemodynamically stable after fluids. This clearly describes an early, large post-pneumonectomy bronchopleural fistula with established empyema.\nManagement principle is staged: urgent, effective drainage and control of infected pleural space, then delayed definitive stump repair and obliteration of cavity once infection controlled. Option B (open window thoracostomy/Eloesser) best matches standard thoracic surgery teaching for large BPF with empyema.\nOption A (immediate thoracoplasty with flap) is discouraged in contaminated, infected fields due to high failure and sepsis risk. C (endoscopic closure with fibrin glue/stent) is reserved for small stump leaks without empyema. D (chest tube plus antibiotics) is inadequate for a large fistula with a pneumonectomy space empyema. E (transsternal transpericardial re-closure) is occasionally used for access to stumps but not as first-line in a grossly infected cavity.\nNo major medical inaccuracies identified.\nMinimal fix: Specify “large post-pneumonectomy bronchopleural fistula with empyema” in the stem to explicitly anchor the diagnosis and intent of management stage.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-010", "question": "A 68-year-old man with a 6.2 cm infrarenal abdominal aortic aneurysm undergoes elective endovascular aneurysm repair (EVAR). The proximal neck is 11 mm in length with 45-degree angulation and 28 mm diameter. Intraoperative completion angiography shows a type Ia endoleak. Multiple ballooning of the proximal seal zone fails to resolve the endoleak. Which intervention is MOST appropriate at this time?", "options": ["Placement of a Palmaz stent at the proximal seal zone", "Deployment of endoanchors (HeliFlex) at the proximal neck", "Conversion to open surgical repair", "Placement of an aortic extension cuff with suprarenal fixation", "Completion of procedure with planned surveillance and secondary intervention"], "answer": "B", "answer_index": 1, "explanation": "Intraoperative type Ia endoleak in a hostile neck (short, angulated) that persists after ballooning requires immediate intervention. Endoanchors (EndoAnchors/HeliFlex) provide transmural fixation that can achieve seal in challenging anatomy and have demonstrated efficacy for intraoperative type Ia endoleaks. A Palmaz stent provides radial force but not fixation and may not address the angulation issue. An extension cuff would not help as the problem is at the existing proximal seal zone. Conversion to open repair is overly morbid when endovascular options remain. Leaving a type Ia endoleak risks continued aneurysm pressurization and rupture.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable; B is reasonable but D is also strongly defensible.\\nKey stem clues: 6.2-cm infrarenal AAA; hostile neck (11-mm length, 45° angulation, 28-mm diameter); intraoperative type Ia endoleak; persistent after aggressive ballooning. Question asks for most appropriate immediate intra-op management.\\nType Ia endoleak at a very short, angulated neck generally implies inadequate proximal seal; standard board-level management emphasizes improving seal with proximal extension (e.g., aortic cuff, sometimes with suprarenal fixation) before adjuncts like anchors. Choice D directly addresses inadequate seal length by moving to healthier aorta. Choice B (endoanchors) is also acceptable: they improve fixation and seal in hostile necks and are specifically marketed for intra-op type I leaks. The stem does not provide information about more proximal neck suitability or device limitations, so it is unclear whether cuff extension is or isn’t feasible. Thus both B and D are plausible best answers under the given data. Other options are less appropriate: Palmaz stent (A) adds radial force but not fixation; C (open conversion) is premature; E (observe) is unsafe.\\nMinimal fix: Specify that there is no additional healthy proximal neck available for cuff extension, or remove D, to make B uniquely correct.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable; B is reasonable but D is also strongly defensible.\nKey stem clues: 6.2-cm infrarenal AAA; hostile neck (11-mm length, 45° angulation, 28-mm diameter); intraoperative type Ia endoleak; persistent after aggressive ballooning. Question asks for most appropriate immediate intra-op management.\nType Ia endoleak at a very short, angulated neck generally implies inadequate proximal seal; standard board-level management emphasizes improving seal with proximal extension (e.g., aortic cuff, sometimes with suprarenal fixation) before adjuncts like anchors. Choice D directly addresses inadequate seal length by moving to healthier aorta. Choice B (endoanchors) is also acceptable: they improve fixation and seal in hostile necks and are specifically marketed for intra-op type I leaks. The stem does not provide information about more proximal neck suitability or device limitations, so it is unclear whether cuff extension is or isn’t feasible. Thus both B and D are plausible best answers under the given data. Other options are less appropriate: Palmaz stent (A) adds radial force but not fixation; C (open conversion) is premature; E (observe) is unsafe.\nMinimal fix: Specify that there is no additional healthy proximal neck available for cuff extension, or remove D, to make B uniquely correct.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-011", "question": "A 16-year-old competitive gymnast presents with 8 months of progressive low back pain that worsens with extension and rotation. She has point tenderness over the L5 spinous process. Standing lateral radiographs reveal grade I L5-S1 spondylolisthesis. SPECT-CT demonstrates bilateral L5 pars defects with intense radiotracer uptake. MRI shows bone marrow edema at the pars without disc degeneration. After 4 months of bracing and activity modification, she has persistent pain and SPECT-CT shows continued uptake. Which surgical intervention offers the BEST outcome for return to sport?", "options": ["L5-S1 posterolateral fusion with pedicle screw fixation", "Direct pars repair with Buck's screw technique", "Direct pars repair with pedicle screw-hook-rod construct and bone grafting", "L5-S1 anterior lumbar interbody fusion", "Minimally invasive transforaminal lumbar interbody fusion"], "answer": "C", "answer_index": 2, "explanation": "For young athletes with symptomatic bilateral spondylolysis refractory to conservative management, direct pars repair preserves motion and offers the best chance for return to high-level athletics. The pedicle screw-hook-rod construct (Scott wiring modification) with bone grafting provides superior biomechanical stability compared to Buck's screw technique, particularly for bilateral defects. The presence of bone marrow edema and SPECT uptake indicates healing potential. Fusion procedures (posterolateral, ALIF, TLIF) sacrifice motion segments and are reserved for cases with disc degeneration, high-grade slips, or failed direct repair.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 16-year-old elite gymnast, 8 months low back pain worse with extension/rotation; grade I L5–S1 spondylolisthesis; bilateral L5 pars defects; SPECT-CT and MRI show intense uptake and bone marrow edema (active lesion with healing potential), no disc degeneration; failed 4 months of bracing/activity modification; need surgical option optimizing return to sport.\\nMost likely diagnosis/mechanism: Symptomatic bilateral L5 pars interarticularis stress fractures with low-grade isthmic spondylolisthesis, motion segment otherwise healthy and potentially reparable.\\nDirect pars repair is preferred in young athletes with good healing potential and minimal slip to preserve motion and maximize return to high-level sports. Among repair techniques, modern constructs using pedicle screw–hook–rod with bone grafting provide superior biomechanical stability and outcomes for bilateral defects compared with Buck’s screws, making option C the best choice.\\nFusion options (A, D, E) sacrifice the motion segment and are generally reserved for high-grade slips, disc degeneration, or failed repair—none of which are present. Buck’s screw (B) is acceptable but biomechanically inferior to C.\\nMain medical accuracy issues: None significant; item aligns with contemporary spine-sports practice.\\nMinimal fix: Clarify “low-grade (Meyerding grade I) isthmic spondylolisthesis with preserved disc height and signal” to reinforce fusion not yet indicated.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 16-year-old elite gymnast, 8 months low back pain worse with extension/rotation; grade I L5–S1 spondylolisthesis; bilateral L5 pars defects; SPECT-CT and MRI show intense uptake and bone marrow edema (active lesion with healing potential), no disc degeneration; failed 4 months of bracing/activity modification; need surgical option optimizing return to sport.\nMost likely diagnosis/mechanism: Symptomatic bilateral L5 pars interarticularis stress fractures with low-grade isthmic spondylolisthesis, motion segment otherwise healthy and potentially reparable.\nDirect pars repair is preferred in young athletes with good healing potential and minimal slip to preserve motion and maximize return to high-level sports. Among repair techniques, modern constructs using pedicle screw–hook–rod with bone grafting provide superior biomechanical stability and outcomes for bilateral defects compared with Buck’s screws, making option C the best choice.\nFusion options (A, D, E) sacrifice the motion segment and are generally reserved for high-grade slips, disc degeneration, or failed repair—none of which are present. Buck’s screw (B) is acceptable but biomechanically inferior to C.\nMain medical accuracy issues: None significant; item aligns with contemporary spine-sports practice.\nMinimal fix: Clarify “low-grade (Meyerding grade I) isthmic spondylolisthesis with preserved disc height and signal” to reinforce fusion not yet indicated.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-012", "question": "A 35-year-old man presents with a 3-year history of recurrent painful nodules on his axillae, groin, and buttocks that drain purulent material. Examination reveals sinus tracts, bridged scars, and multiple inflammatory nodules in these areas. He has failed multiple courses of antibiotics including doxycycline and clindamycin/rifampin combination. His Hurley stage is III. BMI is 34. He is started on adalimumab with initial improvement, but after 6 months develops new inflammatory nodules and draining sinuses in the axillae. Which intervention is MOST likely to achieve durable disease control?", "options": ["Switch to infliximab with dose escalation protocol", "Add oral zinc gluconate and metformin to adalimumab", "Wide local excision of affected axillary tissue with healing by secondary intention", "Combination adalimumab with Nd:YAG laser therapy", "Incision and drainage of active nodules with intralesional triamcinolone"], "answer": "C", "answer_index": 2, "explanation": "Hurley stage III hidradenitis suppurativa refractory to biologic therapy requires surgical intervention for durable disease control. Wide local excision with removal of all hair-bearing tissue in the affected region, healing by secondary intention or skin grafting, provides the lowest recurrence rates (0-15%) compared to limited excision or deroofing. Switching biologics rarely achieves control in Hurley III disease that has failed adalimumab. Laser therapy is adjunctive and insufficient for established sinus tracts. Incision and drainage provides only temporary relief. The extensive scarring and sinus tract formation indicate irreversible tissue damage requiring excision.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 3-year history of classic hidradenitis suppurativa involving axillae/groin/buttocks; sinus tracts and bridged scars; Hurley stage III; failed multiple systemic antibiotics including clindamycin/rifampin; obese; initial response then secondary failure to adalimumab after 6 months with new nodules and draining sinuses. These features indicate severe, refractory, structurally damaged HS where medical therapy is unlikely to provide durable control, and definitive surgery is standard.\\nOption C (wide local excision with healing by secondary intention) aligns with guideline-based management for Hurley III, showing lowest recurrence and durable disease control. \\nOption A: Switching to infliximab may help some HS patients but is less reliable than definitive surgery in advanced Hurley III with extensive sinus tracts.\\nOption B: Zinc and metformin are adjunctive and more appropriate for milder or earlier disease; insufficient for severe refractory Hurley III.\\nOption D: Nd:YAG laser is adjunctive for hair follicle destruction, not definitive for extensive sinus tracts and scarring.\\nOption E: I&D with intralesional steroid is palliative/short-term, not durable control.\\nNo internal contradictions or underspecification. \\nMinimal fix: Explicitly state “extensive confluent sinus tracts and scarring throughout the axilla” to further justify wide excision as preferred over any additional medical escalation.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 3-year history of classic hidradenitis suppurativa involving axillae/groin/buttocks; sinus tracts and bridged scars; Hurley stage III; failed multiple systemic antibiotics including clindamycin/rifampin; obese; initial response then secondary failure to adalimumab after 6 months with new nodules and draining sinuses. These features indicate severe, refractory, structurally damaged HS where medical therapy is unlikely to provide durable control, and definitive surgery is standard.\nOption C (wide local excision with healing by secondary intention) aligns with guideline-based management for Hurley III, showing lowest recurrence and durable disease control. \nOption A: Switching to infliximab may help some HS patients but is less reliable than definitive surgery in advanced Hurley III with extensive sinus tracts.\nOption B: Zinc and metformin are adjunctive and more appropriate for milder or earlier disease; insufficient for severe refractory Hurley III.\nOption D: Nd:YAG laser is adjunctive for hair follicle destruction, not definitive for extensive sinus tracts and scarring.\nOption E: I&D with intralesional steroid is palliative/short-term, not durable control.\nNo internal contradictions or underspecification. \nMinimal fix: Explicitly state “extensive confluent sinus tracts and scarring throughout the axilla” to further justify wide excision as preferred over any additional medical escalation.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-013", "question": "A 58-year-old man undergoes radical cystectomy with ileal conduit urinary diversion for muscle-invasive bladder cancer. On postoperative day 12, he develops fever, abdominal distension, and elevated white blood cell count. CT scan reveals a 6 cm fluid collection adjacent to the ureteroileal anastomosis with surrounding fat stranding. Percutaneous drainage yields 450 mL of fluid with creatinine level of 18 mg/dL (serum creatinine 1.2 mg/dL). Antegrade nephrostogram demonstrates extravasation at the left ureteroileal anastomosis. The patient is hemodynamically stable. Which management approach is MOST appropriate?", "options": ["Immediate surgical exploration with ureteral reimplantation", "Percutaneous nephrostomy tube placement with continued drainage of urinoma", "Retrograde ureteral stent placement via the ileal conduit", "Endoscopic balloon dilation of the ureteroileal anastomosis", "Conservative management with Foley catheter drainage of the ileal conduit"], "answer": "B", "answer_index": 1, "explanation": "Ureteroileal anastomotic leak in a stable patient is best managed with urinary diversion via percutaneous nephrostomy to decompress the collecting system and allow the anastomosis to heal, combined with drainage of the urinoma. This approach allows most leaks to heal within 4-6 weeks. Immediate surgical exploration in the early postoperative period with inflammation and potential infection carries high morbidity. Retrograde stenting through an ileal conduit is technically challenging and often unsuccessful. Balloon dilation is for strictures, not acute leaks. Simple conduit drainage does not adequately decompress the system proximal to the leak.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Recent radical cystectomy with ileal conduit; POD 12; fever, leukocytosis, abdominal collection adjacent to ureteroileal anastomosis; high creatinine in drained fluid indicating urinoma; antegrade nephrostogram showing extravasation at left ureteroileal anastomosis; patient hemodynamically stable. This defines an early ureteroileal anastomotic leak with a drained urinoma in a stable patient.\\nManagement principle: For a stable patient with postoperative urinary leak at a ureteroenteric anastomosis, standard of care is urinary diversion via percutaneous nephrostomy plus drainage, allowing the anastomosis to heal without high‑morbidity reoperation.\\nChoice B (percutaneous nephrostomy tube placement with continued drainage) directly addresses proximal decompression and matches guidelines and common urologic practice.\\nWhy others are worse: A (immediate surgical exploration) is reserved for unstable patients, sepsis not controlled by drainage, or failed conservative therapy. C (retrograde stent via conduit) is technically difficult and less reliable than antegrade access. D (balloon dilation) is a treatment for strictures, not acute leaks. E (Foley to conduit) does not decompress the collecting system above the leak.\\nMinimal fix: None strictly required; item is already clear and accurate. Optionally, specify that appropriate antibiotics are being given to reflect full management.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Recent radical cystectomy with ileal conduit; POD 12; fever, leukocytosis, abdominal collection adjacent to ureteroileal anastomosis; high creatinine in drained fluid indicating urinoma; antegrade nephrostogram showing extravasation at left ureteroileal anastomosis; patient hemodynamically stable. This defines an early ureteroileal anastomotic leak with a drained urinoma in a stable patient.\nManagement principle: For a stable patient with postoperative urinary leak at a ureteroenteric anastomosis, standard of care is urinary diversion via percutaneous nephrostomy plus drainage, allowing the anastomosis to heal without high‑morbidity reoperation.\nChoice B (percutaneous nephrostomy tube placement with continued drainage) directly addresses proximal decompression and matches guidelines and common urologic practice.\nWhy others are worse: A (immediate surgical exploration) is reserved for unstable patients, sepsis not controlled by drainage, or failed conservative therapy. C (retrograde stent via conduit) is technically difficult and less reliable than antegrade access. D (balloon dilation) is a treatment for strictures, not acute leaks. E (Foley to conduit) does not decompress the collecting system above the leak.\nMinimal fix: None strictly required; item is already clear and accurate. Optionally, specify that appropriate antibiotics are being given to reflect full management.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-014", "question": "A 55-year-old woman presents with progressive hearing loss, tinnitus, and imbalance over 2 years. Audiometry reveals asymmetric sensorineural hearing loss with word recognition score of 48% on the right. MRI shows a 2.8 cm right vestibular schwannoma with brainstem compression. She desires hearing preservation if possible. ABR shows prolonged wave I-V interpeak latency. Which treatment approach offers the BEST chance of serviceable hearing preservation while achieving tumor control?", "options": ["Translabyrinthine approach for complete tumor resection", "Retrosigmoid approach with intraoperative auditory monitoring", "Middle fossa approach with facial nerve monitoring", "Gamma Knife stereotactic radiosurgery (12-13 Gy marginal dose)", "Fractionated stereotactic radiotherapy (50.4 Gy in 28 fractions)"], "answer": "E", "answer_index": 4, "explanation": "For vestibular schwannomas >2.5 cm with brainstem compression where hearing preservation is desired, fractionated stereotactic radiotherapy (FSRT) offers superior hearing preservation rates (60-80%) compared to single-fraction radiosurgery (40-50%) while maintaining excellent tumor control. The larger tumor size with brainstem compression makes single-fraction SRS less ideal due to toxicity concerns. Surgical approaches for tumors this size have poor hearing preservation rates (<30%). The translabyrinthine approach sacrifices hearing by design. The middle fossa approach is limited to tumors <1.5 cm in the internal auditory canal. The prolonged ABR suggests cochlear nerve dysfunction making surgical hearing preservation unlikely.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 55-year-old with progressive unilateral sensorineural hearing loss, poor word recognition (48%), 2.8‑cm vestibular schwannoma with brainstem compression, desire for hearing preservation, ABR showing prolonged I–V latency. Tumor size >2.5 cm and brainstem compression make hearing-preservation microsurgery low yield and increase surgical risk; translabyrinthine is explicitly non–hearing sparing; middle fossa is generally reserved for small intracanalicular tumors (<1.5 cm). Single‑fraction Gamma Knife at 12–13 Gy for a 2.8‑cm mass abutting brainstem carries higher risk of cranial neuropathy and worse long‑term hearing than fractionated stereotactic radiotherapy (FSRT), for which contemporary data support higher serviceable hearing preservation with excellent tumor control in larger lesions.\\nLogical issues: Options are reasonably distinct; only FSRT simultaneously optimizes tumor control, brainstem safety, and hearing preservation for a 2.8‑cm tumor. No internal contradictions or underspecification that would make another option similarly defensible.\\nMedical accuracy issues: Ranges for hearing preservation after FSRT vs SRS are somewhat literature-dependent but within accepted modern ranges; overall management recommendations are consistent with contemporary practice.\\nMinimal fix: Specify “Koos grade IV” or “2.8‑cm tumor contacting/compressing brainstem” in stem to underscore size/brainstem risk and further justify avoiding single‑fraction SRS.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 55-year-old with progressive unilateral sensorineural hearing loss, poor word recognition (48%), 2.8‑cm vestibular schwannoma with brainstem compression, desire for hearing preservation, ABR showing prolonged I–V latency. Tumor size >2.5 cm and brainstem compression make hearing-preservation microsurgery low yield and increase surgical risk; translabyrinthine is explicitly non–hearing sparing; middle fossa is generally reserved for small intracanalicular tumors (<1.5 cm). Single‑fraction Gamma Knife at 12–13 Gy for a 2.8‑cm mass abutting brainstem carries higher risk of cranial neuropathy and worse long‑term hearing than fractionated stereotactic radiotherapy (FSRT), for which contemporary data support higher serviceable hearing preservation with excellent tumor control in larger lesions.\nLogical issues: Options are reasonably distinct; only FSRT simultaneously optimizes tumor control, brainstem safety, and hearing preservation for a 2.8‑cm tumor. No internal contradictions or underspecification that would make another option similarly defensible.\nMedical accuracy issues: Ranges for hearing preservation after FSRT vs SRS are somewhat literature-dependent but within accepted modern ranges; overall management recommendations are consistent with contemporary practice.\nMinimal fix: Specify “Koos grade IV” or “2.8‑cm tumor contacting/compressing brainstem” in stem to underscore size/brainstem risk and further justify avoiding single‑fraction SRS.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-015", "question": "A 32-year-old man sustains a complete C6 ASIA A spinal cord injury in a motor vehicle accident. At 8 months post-injury, he has developed a 4 cm sacral pressure ulcer extending to bone with undermining. He undergoes successful myocutaneous flap closure. During inpatient rehabilitation, he experiences recurrent episodes of severe headache, flushing above the injury level, and blood pressure elevations to 210/120 mmHg. Bladder scan shows 650 mL. After catheterization, symptoms resolve. Which medication regimen provides the MOST effective prophylaxis against future episodes?", "options": ["Scheduled oxybutynin 5 mg TID with PRN nifedipine for acute episodes", "Prazosin 1 mg TID with scheduled tamsulosin", "Scheduled terazosin 5 mg daily with PRN nitropaste for acute episodes", "Propranolol 20 mg TID with PRN hydralazine", "Clonidine 0.1 mg TID with PRN captopril"], "answer": "C", "answer_index": 2, "explanation": "Autonomic dysreflexia (AD) in spinal cord injury above T6 is most commonly triggered by bladder distension. Prophylaxis focuses on preventing triggers and blocking the sympathetic response. Alpha-1 blockers (terazosin, prazosin) are first-line prophylactic agents as they block the peripheral vasoconstriction causing hypertension. Terazosin's longer half-life allows once-daily dosing. For acute episodes, rapid-acting vasodilators like nitropaste (2% nitroglycerin) or nifedipine are appropriate. Beta-blockers are contraindicated as they can worsen hypertension by blocking beta-2 vasodilation while leaving alpha-mediated vasoconstriction unopposed. Oxybutynin addresses bladder spasticity but not the vascular response.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Complete C6 ASIA A injury (above T6), classic autonomic dysreflexia episodes (severe headache, flushing above lesion, BP 210/120) clearly precipitated by bladder overdistension (650 mL, resolution after catheterization). The question asks for the most effective prophylactic regimen against future episodes. Standard management emphasizes trigger prevention and pharmacologic blunting of sympathetic vasoconstriction.\\nOption C (scheduled terazosin with PRN nitropaste) matches guideline-based practice: alpha-1 blockade for prophylaxis plus rapid-onset topical nitrate for acute hypertensive crises. Terazosin’s longer half-life supports once-daily dosing.\\nOption A: oxybutynin may reduce bladder spasms but does not directly blunt the vascular response; nifedipine PRN alone is not optimal prophylaxis. Option B: dual alpha blockade (prazosin+tamsulosin) is excessive and atypical; tamsulosin is more lower-urinary-tract specific, less systemic antihypertensive. Options D and E: beta-blocker or clonidine regimens are not first-line and can be problematic in AD (beta-blockade may worsen hypertension; clonidine is not standard prophylaxis).\\nMain medical issues: Minor—beta-blockers are generally avoided but data are limited; teaching point is standard. Minimal fix: Explicitly state “above T6” in the stem to reinforce classic AD level criterion.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Complete C6 ASIA A injury (above T6), classic autonomic dysreflexia episodes (severe headache, flushing above lesion, BP 210/120) clearly precipitated by bladder overdistension (650 mL, resolution after catheterization). The question asks for the most effective prophylactic regimen against future episodes. Standard management emphasizes trigger prevention and pharmacologic blunting of sympathetic vasoconstriction.\nOption C (scheduled terazosin with PRN nitropaste) matches guideline-based practice: alpha-1 blockade for prophylaxis plus rapid-onset topical nitrate for acute hypertensive crises. Terazosin’s longer half-life supports once-daily dosing.\nOption A: oxybutynin may reduce bladder spasms but does not directly blunt the vascular response; nifedipine PRN alone is not optimal prophylaxis. Option B: dual alpha blockade (prazosin+tamsulosin) is excessive and atypical; tamsulosin is more lower-urinary-tract specific, less systemic antihypertensive. Options D and E: beta-blocker or clonidine regimens are not first-line and can be problematic in AD (beta-blockade may worsen hypertension; clonidine is not standard prophylaxis).\nMain medical issues: Minor—beta-blockers are generally avoided but data are limited; teaching point is standard. Minimal fix: Explicitly state “above T6” in the stem to reinforce classic AD level criterion.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-016", "question": "A 45-year-old woman undergoes bilateral breast reconstruction with tissue expanders following mastectomy for DCIS. At 6 weeks post-expansion completion, she develops erythema, swelling, and pain of the right breast without fever. Cultures from aspiration grow Mycobacterium fortuitum. The tissue expander is removed and she completes 6 months of appropriate antibiotic therapy with clinical resolution. She now desires completion of reconstruction. Which reconstructive approach carries the LOWEST risk of recurrent infection?", "options": ["Immediate tissue expander replacement with antibiotic irrigation", "Delayed tissue expander placement after 6 months observation", "Autologous reconstruction with pedicled latissimus dorsi flap", "Autologous reconstruction with free DIEP flap", "Direct-to-implant reconstruction with acellular dermal matrix"], "answer": "D", "answer_index": 3, "explanation": "Following nontuberculous mycobacterial (NTM) infection requiring implant removal, autologous reconstruction provides the lowest recurrence risk as it avoids reintroduction of foreign material into a previously infected field. Free tissue transfer (DIEP flap) is preferred over pedicled flaps as it brings well-vascularized tissue from an unaffected donor site without traversing the previously infected chest wall. The latissimus flap, while autologous, requires dissection through potentially contaminated tissue planes. Any implant-based reconstruction (expander or direct-to-implant) carries significant risk of biofilm formation and recurrent NTM infection, even after prolonged antibiotic therapy and observation period.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Prior breast reconstruction with tissue expanders; documented nontuberculous mycobacterial (Mycobacterium fortuitum) infection of the prosthetic device requiring expander removal; 6 months of appropriate antibiotics with clinical resolution; patient now desires completion of reconstruction; question asks which option has the lowest risk of recurrent infection.\\nReasoning: NTM infections of prosthetic breast devices are notorious for biofilm formation and recurrence with reimplantation of foreign material. Thus, implant-based strategies (A: immediate expander replacement, B: delayed expander, E: direct-to-implant with ADM) all reintroduce foreign material into a previously infected field and are logically higher risk. Among autologous options, a free DIEP flap (D) imports well-vascularized, uninvolved tissue and microvascular anastomoses remote from earlier prosthetic pocket, whereas a pedicled latissimus (C) requires dissection through prior potentially contaminated chest wall/tissue planes, theoretically higher recurrence risk. That matches widely accepted principles.\\nMain medical accuracy issues: The explanation is consistent with current understanding of NTM implant infections and autologous vs implant-based reconstruction; no major inaccuracies.\\nMinimal fix: Clarify in the stem that there are no other local contraindications to free flap reconstruction (e.g., abdominal scars or vessel issues) to avoid non-infectious factors confounding the “best” choice.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Prior breast reconstruction with tissue expanders; documented nontuberculous mycobacterial (Mycobacterium fortuitum) infection of the prosthetic device requiring expander removal; 6 months of appropriate antibiotics with clinical resolution; patient now desires completion of reconstruction; question asks which option has the lowest risk of recurrent infection.\nReasoning: NTM infections of prosthetic breast devices are notorious for biofilm formation and recurrence with reimplantation of foreign material. Thus, implant-based strategies (A: immediate expander replacement, B: delayed expander, E: direct-to-implant with ADM) all reintroduce foreign material into a previously infected field and are logically higher risk. Among autologous options, a free DIEP flap (D) imports well-vascularized, uninvolved tissue and microvascular anastomoses remote from earlier prosthetic pocket, whereas a pedicled latissimus (C) requires dissection through prior potentially contaminated chest wall/tissue planes, theoretically higher recurrence risk. That matches widely accepted principles.\nMain medical accuracy issues: The explanation is consistent with current understanding of NTM implant infections and autologous vs implant-based reconstruction; no major inaccuracies.\nMinimal fix: Clarify in the stem that there are no other local contraindications to free flap reconstruction (e.g., abdominal scars or vessel issues) to avoid non-infectious factors confounding the “best” choice.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-017", "question": "A 52-year-old woman presents with a 2-year history of progressive gait difficulty and urinary urgency. MRI reveals a 1.8 cm intradural intramedullary lesion at T8 with homogeneous enhancement and associated syrinx extending from T6 to T10. The lesion has well-defined margins and appears to have a cleavage plane from the spinal cord. Intraoperatively, after myelotomy, a grayish-tan tumor is encountered that appears to have a clear plane from the surrounding cord. Frozen section suggests ependymoma. Which surgical strategy is MOST appropriate?", "options": ["Gross total resection with ultrasonic aspiration of tumor margins", "Gross total resection with en bloc removal maintaining tumor capsule integrity", "Subtotal resection followed by adjuvant radiation therapy", "Biopsy only with planned stereotactic radiosurgery", "Gross total resection with intraoperative radiation to tumor bed"], "answer": "B", "answer_index": 1, "explanation": "Spinal cord ependymomas are typically well-circumscribed tumors with a clear cleavage plane from surrounding neural tissue, making gross total resection (GTR) the treatment of choice with excellent long-term outcomes (>90% 10-year PFS with GTR). En bloc removal maintaining capsule integrity is preferred over piecemeal resection to minimize cord manipulation and reduce recurrence risk from residual tumor cells. Ultrasonic aspiration at margins risks thermal injury to the cord and tumor spillage. Subtotal resection with radiation has inferior outcomes to GTR alone. The presence of a clear plane and characteristic appearance strongly supports attempting complete resection.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Intradural intramedullary T8 lesion, homogeneous enhancement, well-defined margins, clear cleavage plane from cord, intraoperative appearance consistent with a well-circumscribed grayish-tan tumor, and frozen section suggesting ependymoma. These features point to a classic spinal cord ependymoma amenable to complete microsurgical excision.\\n\\nGiven a benign, well-circumscribed intramedullary ependymoma with a clear plane, current standard is gross total resection whenever safely achievable. Among strategies, en bloc removal while maintaining capsule integrity (choice B) best reflects microsurgical principles: minimize cord manipulation, avoid tumor spillage, and optimize oncologic clearance.\\n\\nChoice A (ultrasonic aspiration of tumor margins) risks unnecessary cord trauma and violates capsule integrity; typically used cautiously and internally if at all, not at the interface. C (subtotal + radiation), D (biopsy only + SRS), and E (GTR + intraop radiation) are all inferior or nonstandard for a resectable spinal cord ependymoma with a clear plane.\\n\\nMain medical accuracy issues: None significant; statements about >90% 10-year PFS with GTR and preference for en bloc capsule-preserving resection are consistent with contemporary neurosurgical practice.\\n\\nMinimal fix: Specify that the patient has no major medical or anatomic contraindications to aggressive resection to fully justify GTR as the expected approach.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Intradural intramedullary T8 lesion, homogeneous enhancement, well-defined margins, clear cleavage plane from cord, intraoperative appearance consistent with a well-circumscribed grayish-tan tumor, and frozen section suggesting ependymoma. These features point to a classic spinal cord ependymoma amenable to complete microsurgical excision.\n\nGiven a benign, well-circumscribed intramedullary ependymoma with a clear plane, current standard is gross total resection whenever safely achievable. Among strategies, en bloc removal while maintaining capsule integrity (choice B) best reflects microsurgical principles: minimize cord manipulation, avoid tumor spillage, and optimize oncologic clearance.\n\nChoice A (ultrasonic aspiration of tumor margins) risks unnecessary cord trauma and violates capsule integrity; typically used cautiously and internally if at all, not at the interface. C (subtotal + radiation), D (biopsy only + SRS), and E (GTR + intraop radiation) are all inferior or nonstandard for a resectable spinal cord ependymoma with a clear plane.\n\nMain medical accuracy issues: None significant; statements about >90% 10-year PFS with GTR and preference for en bloc capsule-preserving resection are consistent with contemporary neurosurgical practice.\n\nMinimal fix: Specify that the patient has no major medical or anatomic contraindications to aggressive resection to fully justify GTR as the expected approach.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-018", "question": "A 68-year-old man with HPV-positive oropharyngeal squamous cell carcinoma (T2N1M0, p16+) is treated with definitive intensity-modulated radiation therapy (70 Gy in 35 fractions) with concurrent cisplatin. At 3-month follow-up, PET-CT shows complete metabolic response. At 18 months, he develops progressive dysphagia and weight loss. Modified barium swallow reveals severe pharyngeal dysmotility with aspiration. Direct laryngoscopy shows no tumor recurrence but severe pharyngeal fibrosis with reduced epiglottic deflection. Which factor during his initial treatment MOST strongly predicts this complication?", "options": ["Mean dose to the superior pharyngeal constrictor muscle >60 Gy", "Maximum dose to the larynx >70 Gy", "Mean dose to the parotid glands >26 Gy", "Volume of oral cavity receiving >40 Gy", "Mean dose to the cervical esophagus >45 Gy"], "answer": "A", "answer_index": 0, "explanation": "Severe late dysphagia with pharyngeal dysmotility following head and neck radiation is most strongly associated with dose to the pharyngeal constrictor muscles, particularly the superior and middle constrictors. The QUANTEC guidelines and subsequent studies identify mean pharyngeal constrictor dose >60 Gy as a significant predictor of severe dysphagia. Modern IMRT planning prioritizes constrictor sparing when oncologically feasible. While laryngeal dose affects aspiration risk and parotid dose affects xerostomia, the described pattern of pharyngeal dysmotility with reduced epiglottic deflection specifically implicates constrictor muscle fibrosis. Esophageal dose correlates more with stricture than dysmotility.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: HPV-positive oropharyngeal SCC treated definitively to 70 Gy with concurrent cisplatin; late (18-month) onset progressive dysphagia with weight loss; modified barium swallow showing severe pharyngeal dysmotility with aspiration; laryngoscopy showing no recurrence but severe pharyngeal fibrosis and reduced epiglottic deflection. This points to late radiation-associated dysphagia driven by pharyngeal constrictor fibrosis rather than xerostomia or primary esophageal stricture.\\nOption A (mean dose to superior pharyngeal constrictor >60 Gy) aligns with QUANTEC and subsequent data that pharyngeal constrictor dose is the strongest dosimetric predictor of severe late dysphagia/aspiration. Option B (laryngeal max dose) is less predictive than constrictor mean dose; C (parotid) relates mainly to xerostomia; D (oral cavity V40) to mucositis and subacute dysphagia; E (cervical esophagus dose) to strictures, not primarily pharyngeal dysmotility.\\nNo internal contradictions or need for extra assumptions; the pattern clearly favors constrictor fibrosis and A is uniquely best.\\nMinimal fix: Add an explicit statement like “Dose–volume histogram analysis later showed high mean dose to the superior pharyngeal constrictor,” if wanting to tie vignette more directly to option A, though not strictly necessary.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: HPV-positive oropharyngeal SCC treated definitively to 70 Gy with concurrent cisplatin; late (18-month) onset progressive dysphagia with weight loss; modified barium swallow showing severe pharyngeal dysmotility with aspiration; laryngoscopy showing no recurrence but severe pharyngeal fibrosis and reduced epiglottic deflection. This points to late radiation-associated dysphagia driven by pharyngeal constrictor fibrosis rather than xerostomia or primary esophageal stricture.\nOption A (mean dose to superior pharyngeal constrictor >60 Gy) aligns with QUANTEC and subsequent data that pharyngeal constrictor dose is the strongest dosimetric predictor of severe late dysphagia/aspiration. Option B (laryngeal max dose) is less predictive than constrictor mean dose; C (parotid) relates mainly to xerostomia; D (oral cavity V40) to mucositis and subacute dysphagia; E (cervical esophagus dose) to strictures, not primarily pharyngeal dysmotility.\nNo internal contradictions or need for extra assumptions; the pattern clearly favors constrictor fibrosis and A is uniquely best.\nMinimal fix: Add an explicit statement like “Dose–volume histogram analysis later showed high mean dose to the superior pharyngeal constrictor,” if wanting to tie vignette more directly to option A, though not strictly necessary.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-019", "question": "A 63-year-old man undergoes right upper lobectomy via video-assisted thoracoscopic surgery (VATS) for a 2.5 cm adenocarcinoma. On postoperative day 3, chest tube output increases to 800 mL of milky fluid over 24 hours. Pleural fluid triglycerides are 380 mg/dL and chylomicrons are present. He is started on NPO with total parenteral nutrition. After 7 days, output remains 500-600 mL daily. Lymphangiography shows the leak originating from the thoracic duct at the T10 level. Which intervention is MOST appropriate?", "options": ["Continue conservative management for an additional 7 days", "Thoracic duct embolization via percutaneous approach", "VATS thoracic duct ligation at the level of the leak", "Right thoracotomy with mass ligation of thoracic duct at the diaphragmatic hiatus", "Pleurodesis with talc slurry via chest tube"], "answer": "B", "answer_index": 1, "explanation": "Chylothorax following pulmonary resection that persists beyond 5-7 days of conservative management (NPO/TPN or medium-chain triglyceride diet) with output >500 mL/day warrants intervention. Thoracic duct embolization (TDE) has emerged as the first-line interventional approach with success rates of 70-90% and lower morbidity than surgical ligation. The lymphangiography has already localized the leak, facilitating embolization. Surgical ligation is reserved for TDE failure. Mass ligation at the diaphragmatic hiatus is effective but more invasive. Continued conservative management beyond 2 weeks risks malnutrition and immunocompromise. Pleurodesis does not address the underlying leak and has poor success for high-output chylothorax.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Post-lobectomy chylothorax; milky drainage with triglycerides 380 mg/dL and chylomicrons present; high-output (800 then 500–600 mL/day); failure of 7 days of optimal conservative therapy (NPO, TPN); leak localized on lymphangiography to thoracic duct at T10. These define a persistent, high-output postoperative chylothorax after adequate conservative trial with an anatomically localized duct injury.\\nThoracic duct embolization via percutaneous approach (B) is now widely accepted as the preferred next intervention: minimally invasive, 70–90% success, and especially appropriate after successful lymphangiography/localization. A (continue conservative management) is less appropriate given high persistent output after 7 days and nutritional/immunologic risks. C (VATS ligation at leak) and D (right thoracotomy with mass ligation) are reasonable but more invasive and generally reserved for failure of TDE or when TDE is unavailable. E (pleurodesis) has poor efficacy for high-output chyle and does not correct the leak mechanism.\\nNo internal contradictions or underspecification; a single best option exists and matches the key.\\nMinimal fix: Specify that percutaneous embolization is available at this center to preclude local-resource debates about first-line interventional choice.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Post-lobectomy chylothorax; milky drainage with triglycerides 380 mg/dL and chylomicrons present; high-output (800 then 500–600 mL/day); failure of 7 days of optimal conservative therapy (NPO, TPN); leak localized on lymphangiography to thoracic duct at T10. These define a persistent, high-output postoperative chylothorax after adequate conservative trial with an anatomically localized duct injury.\nThoracic duct embolization via percutaneous approach (B) is now widely accepted as the preferred next intervention: minimally invasive, 70–90% success, and especially appropriate after successful lymphangiography/localization. A (continue conservative management) is less appropriate given high persistent output after 7 days and nutritional/immunologic risks. C (VATS ligation at leak) and D (right thoracotomy with mass ligation) are reasonable but more invasive and generally reserved for failure of TDE or when TDE is unavailable. E (pleurodesis) has poor efficacy for high-output chyle and does not correct the leak mechanism.\nNo internal contradictions or underspecification; a single best option exists and matches the key.\nMinimal fix: Specify that percutaneous embolization is available at this center to preclude local-resource debates about first-line interventional choice.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-020", "question": "A 72-year-old man with a history of open infrarenal AAA repair 15 years ago presents with melena and hemoglobin of 6.8 g/dL. Upper endoscopy reveals a pulsatile mass eroding into the third portion of the duodenum with adherent clot. CT angiography confirms an aortoenteric fistula at the proximal anastomosis with a 4 cm pseudoaneurysm. He is hemodynamically stabilized with transfusion. Which definitive management strategy offers the BEST balance of durability and survival?", "options": ["Endovascular aortic stent graft placement with duodenal repair", "Extra-anatomic axillobifemoral bypass with graft excision and aortic stump closure", "In-situ reconstruction with cryopreserved aortic allograft after graft excision", "In-situ reconstruction with rifampin-soaked Dacron graft and omental wrap", "Endovascular stent graft as bridge to delayed open reconstruction"], "answer": "C", "answer_index": 2, "explanation": "Aortoenteric fistula (AEF) is a life-threatening complication requiring definitive surgical management. In-situ reconstruction with cryopreserved aortic allograft provides the best combination of infection resistance and durability, with lower reinfection rates (5-10%) compared to prosthetic grafts (20-30%) and better long-term patency than extra-anatomic bypass. Extra-anatomic bypass has high rates of aortic stump blowout and graft thrombosis. Endovascular repair alone does not address the infected field and has high failure rates for AEF. Rifampin-soaked Dacron has higher reinfection rates than allograft in this contaminated setting. The duodenum must also be repaired or resected with the definitive procedure.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Elderly man, prior open infrarenal AAA repair, now with melena and CT angiography–confirmed aortoenteric fistula at proximal anastomosis with pseudoaneurysm; hemodynamically stabilized. The question explicitly asks for the definitive management with the best balance of durability and survival in the setting of an infected aortoenteric fistula after prior prosthetic repair.\\nOption C (in-situ reconstruction with cryopreserved aortic allograft after graft excision) is consistent with current vascular surgery practice: it combines removal of the infected graft, maintains in-line flow, and uses biologic graft material with lower reinfection rates and good durability, making it the best single answer.\\nOption B (extra-anatomic bypass with stump) has higher stump blowout and thrombosis; inferior durability and survival. Option D (rifampin Dacron) has higher reinfection risk in grossly contaminated fields. Options A and E rely on endovascular stent grafts in an infected field and are considered temporizing/bridge, not definitive, strategies.\\nMain medical issues: None significant; explanation is aligned with contemporary data. \\nMinimal fix: Explicitly state that the patient is an acceptable candidate for major open reconstruction to avoid ambiguity about operative risk driving an endovascular-first approach.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Elderly man, prior open infrarenal AAA repair, now with melena and CT angiography–confirmed aortoenteric fistula at proximal anastomosis with pseudoaneurysm; hemodynamically stabilized. The question explicitly asks for the definitive management with the best balance of durability and survival in the setting of an infected aortoenteric fistula after prior prosthetic repair.\nOption C (in-situ reconstruction with cryopreserved aortic allograft after graft excision) is consistent with current vascular surgery practice: it combines removal of the infected graft, maintains in-line flow, and uses biologic graft material with lower reinfection rates and good durability, making it the best single answer.\nOption B (extra-anatomic bypass with stump) has higher stump blowout and thrombosis; inferior durability and survival. Option D (rifampin Dacron) has higher reinfection risk in grossly contaminated fields. Options A and E rely on endovascular stent grafts in an infected field and are considered temporizing/bridge, not definitive, strategies.\nMain medical issues: None significant; explanation is aligned with contemporary data. \nMinimal fix: Explicitly state that the patient is an acceptable candidate for major open reconstruction to avoid ambiguity about operative risk driving an endovascular-first approach.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]